NCT00496275View on ClinicalTrials.gov

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

May 31, 2007

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Zactima (ZD6474)

DRUG

Vinorelbine plus cisplatin

DRUG

Gemcitabine plus cisplatin

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00496275 - Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC | Biotech Hunter | Biotech Hunter